Looking ahead and beyond 2016

This is a preview of subscriber content

Subscribe now to continue reading.

In the second part of a two-part series looking at the year ahead, PharmaDispatch considers how long-term strategic influences on the environment are driving tactical issues. Maybe the pharmaceutical sector's biggest challenge in 2016 is looking beyond these tactical issues with the goal of shaping the next round of major reform …

Subscribe now to continue reading.

Looking ahead and beyond 2016

This is a preview of subscriber content

Latest Video

Most Read

Across-the-board PBS levy would simply be a tax on the listing and pricing process

Priceline Pharmacy launches annual event with national menopause project

Pharmacy Guild says Healthscope collapse provides 'stark warning'

Arrotex Pharmaceuticals appointed exclusive partner for Juniper Biologics

For patients, it's about understanding their experience and accessing the touchpoints

New Stories

Dimerix says first ACTION3 trial site activated in Japan and first milestone payment triggered

Arrotex Pharmaceuticals appointed exclusive partner for Juniper Biologics

TGA approves new therapy for children with growth hormone deficiency

AbbVie Australia appoints Dr Carly Levetan associate medical director

For patients, it's about understanding their experience and accessing the touchpoints

Priceline Pharmacy launches annual event with national menopause project

Anne Ruston welcomes her reappointment to health and the addition of NDIS

Sign In

Looking ahead and beyond 2016

This is a preview of subscriber content

Latest Video

Most Read

Across-the-board PBS levy would simply be a tax on the listing and pricing process

Priceline Pharmacy launches annual event with national menopause project

Pharmacy Guild says Healthscope collapse provides 'stark warning'

Arrotex Pharmaceuticals appointed exclusive partner for Juniper Biologics

For patients, it's about understanding their experience and accessing the touchpoints

Follow Us

New Stories

Dimerix says first ACTION3 trial site activated in Japan and first milestone payment triggered

Arrotex Pharmaceuticals appointed exclusive partner for Juniper Biologics

TGA approves new therapy for children with growth hormone deficiency

AbbVie Australia appoints Dr Carly Levetan associate medical director

For patients, it's about understanding their experience and accessing the touchpoints

Priceline Pharmacy launches annual event with national menopause project

Anne Ruston welcomes her reappointment to health and the addition of NDIS